PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

被引:1639
作者
Francisco, Loise M. [1 ,2 ]
Salinas, Victor H. [4 ]
Brown, Keturah E. [1 ]
Vanguri, Vijay K. [1 ,2 ]
Freeman, Gordon J. [5 ]
Kuchroo, Vijay K. [3 ]
Sharpe, Arlene H. [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA
[4] Harvard Univ, Cambridge, MA 02138 USA
[5] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
TRANSCRIPTION FACTOR FOXP3; PROGRAMMED DEATH-1 LIGAND-1; GASTRIC EPITHELIAL-CELLS; CUTTING EDGE; DE-NOVO; CLINICAL-SIGNIFICANCE; TUMOR-IMMUNOTHERAPY; SUPPRESSOR FUNCTION; B7-H1; EXPRESSION; IMMUNE EVASION;
D O I
10.1084/jem.20090847
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Both the programmed death (PD) 1-PD-ligand (PD-L) pathway and regulatory T (T reg) cells are instrumental to the maintenance of peripheral tolerance. We demonstrate that PD-L1 has a pivotal role in regulating induced T reg (iT reg) cell development and sustaining iT reg cell function. PD-L1(-/-) antigen-presenting cells minimally convert naive CD4 T cells to iT reg cells, showing the essential role of PD-L1 for iT reg cell induction. PD-L1-coated beads induce iT reg cells in vitro, indicating that PD-L1 itself regulates iT reg cell development. Furthermore, PD-L1 enhances and sustains Foxp3 expression and the suppressive function of iT reg cells. The obligatory role for PD-L1 in controlling iT reg cell development and function in vivo is illustrated by a marked reduction in iT reg cell conversion and rapid onset of a fatal inflammatory phenotype in PD-L1(-/-)PD-L2(-/-)Rag(-/-) recipients of naive CD4 T cells. PD-L1 iT reg cell development is mediated through the down-regulation of phospho-Akt, mTOR, S6, and ERK2 and concomitant with the up-regulation of PTEN, all key signaling molecules which are critical for iT reg cell development. Thus, PD-L1 can inhibit T cell responses by promoting both the induction and maintenance of iT reg cells. These studies define a novel mechanism for iT reg cell development and function, as well as a new strategy for controlling T reg cell plasticity.
引用
收藏
页码:3015 / 3029
页数:15
相关论文
共 78 条
[51]   Cutting edge:: TGF-β-induced expression of Foxp3 in T cells is mediated through inactivation of ERK [J].
Luo, Xunrong ;
Zhang, Qiang ;
Liu, Victoria ;
Xia, Zhenbiao ;
Pothoven, Kathryn L. ;
Lee, Chung .
JOURNAL OF IMMUNOLOGY, 2008, 180 (05) :2757-2761
[52]   TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells [J].
Marie, JC ;
Letterio, JJ ;
Gavin, M ;
Rudensky, AY .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (07) :1061-1067
[53]   Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers [J].
Nakanishi, Juro ;
Wada, Yoshihiro ;
Matsumoto, Koichiro ;
Azuma, Miyuki ;
Kikuchi, Ken ;
Ueda, Shoichi .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (08) :1173-1182
[54]   Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer [J].
Nomi, Takeo ;
Sho, Masayuki ;
Akahori, Takahiro ;
Hamada, Kaoru ;
Kubo, Atsushi ;
Kanehiro, Hiromichi ;
Nakamura, Shinji ;
Enomoto, Koji ;
Yagita, Hideo ;
Azuma, Miyuki ;
Nakajima, Yoshiyuki .
CLINICAL CANCER RESEARCH, 2007, 13 (07) :2151-2157
[55]   Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer [J].
Ohigashi, Y ;
Sho, M ;
Yamada, Y ;
Tsurui, Y ;
Hamada, K ;
Ikeda, N ;
Mizuno, T ;
Yoriki, R ;
Kashizuka, H ;
Yane, K ;
Tsushima, F ;
Otsuki, N ;
Yagita, H ;
Azuma, M ;
Nakajima, Y .
CLINICAL CANCER RESEARCH, 2005, 11 (08) :2947-2953
[56]   Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4 [J].
Probst, HC ;
McCoy, K ;
Okazaki, T ;
Honjo, T ;
van den Broek, M .
NATURE IMMUNOLOGY, 2005, 6 (03) :280-286
[57]   TGF-β1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets [J].
Pyzik, M. ;
Piccirillo, C. A. .
JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 82 (02) :335-346
[58]   The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice [J].
Qu, Yanyan ;
Zhang, Baojun ;
Zhao, Liang ;
Liu, Guangwei ;
Ma, Haixia ;
Rao, Enyu ;
Zeng, Chun ;
Zhao, Yong .
TRANSPLANT IMMUNOLOGY, 2007, 17 (03) :153-161
[59]   Foxp3 and natural regulatory T cells: Key to a cell lineage? [J].
Ramsdell, F .
IMMUNITY, 2003, 19 (02) :165-168
[60]   Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors [J].
Riley, JL ;
Mao, M ;
Kobayashi, S ;
Biery, M ;
Burchard, J ;
Cavet, G ;
Gregson, BP ;
June, CH ;
Linsley, PS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11790-11795